Yinyin Guo1, Yichen Guo2, Yanxin Luo3, Xia Song1, Hui Zhao1, Laiyuan Li4. 1. Lanzhou University Second Hospital, Lanzhou, China. 2. Department of Emergency, The First Hospital of Lanzhou University, Lanzhou, China. 3. Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. 4. Department of Anorectal Surgery, Gansu Provincial Hospital, Lanzhou, China.
Abstract
OBJECTIVE: The application of robotic surgery for rectal cancer is increasing steadily. The purpose of this meta-analysis is to compare pathologic outcomes among patients with rectal cancer who underwent open rectal surgery (ORS) versus robotic rectal surgery (RRS). METHODS: We systematically searched the literature of EMBASE, PubMed, the Cochrane Library of randomized controlled trials (RCTs) and nonrandomized controlled trials (nRCTs) comparing ORS with RRS. RESULTS: Fourteen nRCTs, including 2711 patients met the predetermined inclusion criteria and were included in the meta-analysis. Circumferential resection margin (CRM) positivity (OR: 0.58, 95% CI, 0.29 to 1.16, P = 0.13), number of harvested lymph nodes (WMD: -0.31, 95% CI, -2.16 to 1.53, P = 0.74), complete total mesorectal excision (TME) rates (OR: 0.93, 95% CI, 0.48 to 1.78, P = 0.83) and the length of distal resection margins (DRM) (WMD: -0.01, 95% CI, -0.26 to 0.25, P = 0.96) did not differ significantly between the RRS and ORS groups. CONCLUSION: Based on the current evidence, robotic resection for rectal cancer provided equivalent pathological outcomes to ORS in terms of CRM positivity, number of harvested lymph nodes and complete TME rates and DRM.
OBJECTIVE: The application of robotic surgery for rectal cancer is increasing steadily. The purpose of this meta-analysis is to compare pathologic outcomes among patients with rectal cancer who underwent open rectal surgery (ORS) versus robotic rectal surgery (RRS). METHODS: We systematically searched the literature of EMBASE, PubMed, the Cochrane Library of randomized controlled trials (RCTs) and nonrandomized controlled trials (nRCTs) comparing ORS with RRS. RESULTS: Fourteen nRCTs, including 2711 patients met the predetermined inclusion criteria and were included in the meta-analysis. Circumferential resection margin (CRM) positivity (OR: 0.58, 95% CI, 0.29 to 1.16, P = 0.13), number of harvested lymph nodes (WMD: -0.31, 95% CI, -2.16 to 1.53, P = 0.74), complete total mesorectal excision (TME) rates (OR: 0.93, 95% CI, 0.48 to 1.78, P = 0.83) and the length of distal resection margins (DRM) (WMD: -0.01, 95% CI, -0.26 to 0.25, P = 0.96) did not differ significantly between the RRS and ORS groups. CONCLUSION: Based on the current evidence, robotic resection for rectal cancer provided equivalent pathological outcomes to ORS in terms of CRM positivity, number of harvested lymph nodes and complete TME rates and DRM.
Authors: Ashwin L deSouza; Leela M Prasad; John Ricci; John J Park; Slawomir J Marecik; Andrea Zimmern; Jennifer Blumetti; Herand Abcarian Journal: Dis Colon Rectum Date: 2011-03 Impact factor: 4.585
Authors: Constantinos Simillis; Nikhil Lal; Sarah N Thoukididou; Christos Kontovounisios; Jason J Smith; Roel Hompes; Michel Adamina; Paris P Tekkis Journal: Ann Surg Date: 2019-07 Impact factor: 12.969
Authors: J P de Jesus; M Valadão; R O de Castro Araujo; D Cesar; E Linhares; A C Iglesias Journal: Eur J Surg Oncol Date: 2016-03-23 Impact factor: 4.424